Hyundai pharm (004310.KS) Financials
004310.KS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-11-30 | 154.6 billion | 70.0 billion |
| 2023-08-31 | 161.2 billion | 73.2 billion |
| 2023-05-31 | 164.8 billion | 76.7 billion |
| 2023-02-28 | 179.8 billion | 93.0 billion |
004310.KS Free Cash Flow and Stock based compensation
No data available :(
004310.KS Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-11-30 | -430.9 million |
| 2023-08-31 | 1.7 billion |
| 2023-05-31 | 3.1 billion |
| 2023-02-28 | 1.7 billion |
004310.KS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-11-30 | - | - | 1.2 billion |
| 2023-08-31 | - | - | 1.0 billion |
| 2023-05-31 | - | - | 499.5 million |
| 2023-02-28 | - | - | 602.1 million |
004310.KS Shares Outstanding
004310.KS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-11-30 | 1.3 billion | 4.1 billion | 8.2 billion | - |
| 2023-08-31 | 1.7 billion | 3.1 billion | 7.7 billion | - |
| 2023-05-31 | 1.9 billion | 3.2 billion | 8.7 billion | - |
| 2023-02-28 | 1.2 billion | 1.9 billion | 6.6 billion | - |
004310.KS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-11-30 | 45.6 billion | 27.6 billion |
| 2023-08-31 | 47.4 billion | 28.5 billion |
| 2023-05-31 | 48.9 billion | 26.3 billion |
| 2023-02-28 | 38.9 billion | 21.8 billion |
004310.KS
Price: ₩3,780
52 week price:
Dividend Yield: 0.89%
Exchange: KSC
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 101.5 billion
Average Dividend Frequency: 1